imipenem, anhydrous has been researched along with Sensitivity and Specificity in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (14.29) | 18.2507 |
2000's | 22 (31.43) | 29.6817 |
2010's | 32 (45.71) | 24.3611 |
2020's | 6 (8.57) | 2.80 |
Authors | Studies |
---|---|
Jing, X; Liu, R; Min, X; Wan, D; Wu, T; Zeng, J; Zhang, X; Zhou, H | 1 |
Ashraf, S; Feng, Y; Hasan, T; Kuriakose, J; Palanisami, A; Pigula, M | 1 |
Cha, YJ; Cho, H; Choi, JE; Heo, W; Kim, JO; Lee, H; Park, YJ; Yoo, IY | 1 |
Conceição, N; da de Cunha Hueb Barata Oliveira, C; da Silva, LEP; de Oliveira, AG; de Oliveira, KLP; de Souza, LRC; Rodrigues, WF | 1 |
Dang, H; Peng, L; Wang, X | 1 |
Aoki, K; Ishii, Y; Morita, T; Murakami, H; Sasaki, M; Tateda, K; Yamada, K | 1 |
Antonelli, A; Barozzi, A; Coppi, M; Fontana, C; Gargiulo, R; Giani, T; Liotti, FM; Mauri, C; Mirandola, W; Principe, L; Rossolini, GM; Spanu, T | 1 |
Chanawong, A; Charoensri, N; Daduang, J; Lulitanond, A; Srisrattakarn, A; Wilailuckana, C | 1 |
Lewis, S; Opene, BNA; Simner, PJ; Tamma, PD; Wang, R | 1 |
Chatelain, P; Fournier, D; Mille, A; Miltgen, G; Plésiat, P | 1 |
Göttig, S; Hamprecht, AG; Saleh, A | 1 |
Chang, KC; Chen, HA; Chin, YC; Chung, CY; Hsu, KH; Hu, A; Huang, SS; Liu, BR; Peng, WP; Soo, PC; Yeh, CH | 1 |
Aubry, A; Bréchot, N; Brossier, F; Jarlier, V; Lu, Q; Luyt, CE; Micaëlo, M; Monsel, A | 1 |
Akeda, Y; Hamada, S; Ishihara, T; Sakamoto, N; Shanmugakani, RK; Shintani, A; Sugawara, Y; Takeuchi, D; Tomono, K; Yamamoto, N | 1 |
Khan, TA; McHugh, TD; Platt, G; Roulston, K; Sohail, M; Uddin, F | 1 |
Fujita, J; Kirikae, T; Kuwahara-Arai, K; Maeda, S; Mya, S; Nakasone, I; Sekiguchi, JI; Tada, T; Tin, HH; Tome, T; Uechi, K; Yanagisawa, I; Zan, KN | 1 |
Capra Pezzi, L; de Souza Barbosa, F; E S Schapoval, E; Franco de Oliveira, T; Manoela Dias Macedo, S; S L Mendez, A; Tsao, M | 1 |
Bartolini, A; Biasolo, MA; Cavallaro, A; Frasson, I; Palù, G; Richter, SN | 1 |
Guzek, A; Korzeniewski, K; Nitsch-Osuch, A; Prokop, E; Rybicki, Z | 1 |
Boucher, BA; Herring, VL; Hickerson, WL; Hu, ZY; Laizure, SC; Parker, RB | 1 |
Arakawa, Y; Hattori, T; Kawamura, K | 1 |
Chiang, YR; Chung, FH; Huang, MC; Lee, HC; Lu, J; Ma, N; Sung, YC; Tseng, AL | 1 |
George, SC; Jayachandran, VP; Kalarikkal, N; Lewu, FB; Mohan, S; Oluwafemi, OS; Songca, SP; Thomas, S | 1 |
Hodsdon, ME; Kulkarni, MV; Murray, TS; Peaper, DR; Pyka, JS; Zurita, AN | 1 |
Bogaerts, P; Cuzon, G; De Saint Martin, L; Glupczynski, Y; Lamar, E; Lasserre, C; Naas, T; Tandé, D | 1 |
Aydın, F; Bayramoğlu, G; Gençoğlu Özgür, Ç; Kılıç, AO; Uluçam, G | 1 |
Burgers, PC; Dekker, LJ; Goessens, WH; Kostzrewa, M; Luider, TM; Monteferrante, CG; Peer, M; Sparbier, K; Sultan, S; Ten Kate, MT | 1 |
Arai, K; Kashiwa, M; Nagano, N; Saito, R; Yamada, K | 1 |
Bou, G; Oviaño, M | 1 |
Barbeyto, LP; Bou, G; Oviaño, M; Ramírez, CL | 1 |
Blanchet, B; Chhun, S; Jullien, V; Lanternier, F; Legrand, T; Pons, G; Rey, E; Zahar, JR | 1 |
Ahn, JB; Hwang, SY; Koo, SH; Lee, SH; Park, SH; Shin, KS; Son, BR | 1 |
Burattini, MN; Caiaffa-Filho, HH; Franco, MR; Rossi, F | 1 |
Corso, A; Lucero, C; Pasteran, F; Rapoport, M; Soloaga, R | 1 |
Benenson, S; Block, C; Cohen, MJ; Hidalgo-Grass, C; Schwartz, C; Temper, V | 1 |
Chiang, T; Colon-Urban, R; Eng, RH; Gomez, E; Huang, DB; Mariano, N; Urban, C | 1 |
Ajao, AO; Furuno, JP; Harris, AD; Johnson, JK; Lee, MS; Ranke, TD; Robinson, G; Venezia, RA | 1 |
Agodi, A; Koumaki, V; Poulou, A; Pournaras, S; Sofianou, D; Themeli-Digalaki, K; Tsakris, A; Voulgari, E; Vrioni, G | 1 |
Chua, EG; Khosravi, Y; Loke, MF; Tay, ST; Vadivelu, J | 1 |
Colakoğlu, S; Durmaz, S; Ekincioğlu, P; Perçin, D | 1 |
Bolmström, A; Gales, A; Qwärnström, A; Walsh, TR | 1 |
Chong, Y; Lee, K; Rossolini, GM; Shin, HB; Yong, D; Yum, JH | 1 |
Gunderson, B; Hermsen, ED; Hovde, LB; Ibrahim, KH; Rotschafer, JC; Rotschafer, SE | 1 |
Chuang, CL; Tsai, SH; Wu, JJ; Yan, JJ | 1 |
Cirioni, O; D'Amato, G; Giacometti, A; Kamysz, W; Lukasiak, J; Scalise, G; Silvestri, C; Simona Del Prete, M | 1 |
Chong, Y; Ha, GY; Jang, SJ; Kang, JO; Kim, JJ; Lee, K; Shin, BM; Yong, D | 1 |
Balaban, N; Cirioni, O; D'Amato, G; Del Prete, MS; Dell'Acqua, G; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G; Silvestri, C | 1 |
Bolmström, A; Chong, Y; Karlsson, A; Lee, K; Lim, YS; Qwärnström, A; Yong, D; Yum, JH | 1 |
Antonopoulou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kentepozidis, N; Plachouras, D; Tsaganos, T | 1 |
Church, DL; Gregson, DB; Le, P; McClure, JA; Pitout, JD; Poirel, L | 1 |
Ballerini, V; Limansky, AS; Marchiaro, P; Mussi, MA; Pasteran, F; Viale, AM; Vila, AJ | 1 |
Aparicio, I; Bello, MA; Callejón, M; Jiménez, JC | 1 |
Caramelo, C; Castilla, M; de Lucas, C; Lazaro, JA; Tejedor, A; Torres, AM | 1 |
Bennett, KM; Dodds-Ashley, E; Hayward, TZ; Kaye, KS; Scarborough, JE; Sharpe, M; Vaslef, SN | 1 |
Bertoluci, DF; Dell'Aquilla, AM; López, KJ; Santos, SR; Vicente, KM | 1 |
Aasnaes, B; Buarø, L; Giske, CG; Samuelsen, O; Simonsen, GS; Sundsfjord, A | 1 |
Giakkoupi, P; Kalapothaki, V; Polemis, M; Tzouvelekis, LS; Vatopoulos, AC; Vourli, S | 1 |
al-Meshal, MA; Lotfi, KM; Ramadan, MA; Shibl, AM | 1 |
Baquero, F; Cantón, R; García de Lomas, J; Gimeno, C; Liñares, J; Martínez-Beltrán, J; Tubau, F | 1 |
Jones, R; Satishchandran, V; Shapiro, T; Suh, B; Truant, AL | 1 |
Grimm, H; Hauss, C; Rodloff, AC | 1 |
Dowzicky, MJ; Nadler, HL; Sheikh, W | 1 |
Alonso, R; Cisterna, R; Colom, K; Fernández-Aranguiz, A; Morla, A; Suinaga, E; Umaran, A | 1 |
Arroyo, C; Bonal, J; Garcia-Capdevila, L; López-Calull, C; Mangues, MA; Moral, MA | 1 |
Cuca, GC; Hammond, GG; Leiting, B; Pompliano, DL; Pryor, KD; Toney, JH; Wu, JK | 1 |
Berger, D; Heinemann, M; Lorenz, I; Möricke, A; Schneider, M; Seidelmann, M; Steinbach, G; Trautmann, M | 1 |
Büchler, MW; Friess, H; Gloor, B; Müller, CA; Seiler, CA; Uhl, W | 1 |
Byl, B; Clevenbergh, P; Jacobs, F; Kentos, A; Marchant, A; Thys, JP; Vincent, JL | 1 |
Friedland, IR; Isaacs, R; Mixson, LA; Motyl, M; Woods, GL | 1 |
Goldmann, DA; Lambert, KG; Macone, AB; O'Rourke, EJ; Parsonnet, KC | 1 |
1 review(s) available for imipenem, anhydrous and Sensitivity and Specificity
Article | Year |
---|---|
Cilastatin protection against cyclosporin A-induced nephrotoxicity: clinical evidence.
Topics: Acute Kidney Injury; Cilastatin; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imipenem; Kidney Function Tests; Male; Probability; Randomized Controlled Trials as Topic; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome | 2007 |
2 trial(s) available for imipenem, anhydrous and Sensitivity and Specificity
Article | Year |
---|---|
Acute necrotizing pancreatitis: treatment strategy according to the status of infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Needle; Chi-Square Distribution; Cholangiopancreatography, Endoscopic Retrograde; Cholecystectomy; Cilastatin; Edema; Female; Humans; Imipenem; Male; Middle Aged; Pancreatitis, Acute Necrotizing; Prospective Studies; Protease Inhibitors; Risk Factors; Sensitivity and Specificity; Statistics, Nonparametric; Thienamycins; Treatment Outcome | 2000 |
Ceftazidime- and imipenem-induced endotoxin release during treatment of gram-negative infections.
Topics: Bacteremia; Ceftazidime; Drug Administration Schedule; Endotoxins; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Injections, Intravenous; Interleukin-6; Male; Probability; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric; Tumor Necrosis Factor-alpha | 2001 |
67 other study(ies) available for imipenem, anhydrous and Sensitivity and Specificity
Article | Year |
---|---|
Differences between meropenem and imipenem disk to detect carbapenemase in gram-negative bacilli using simplified carbapenem inactivation method.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sensitivity and Specificity | 2020 |
Novel Rapid Test for Detecting Carbapenemase.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Imipenem; Microbial Sensitivity Tests; Sensitivity and Specificity | 2020 |
Performance evaluation of automated BD Phoenix NMIC-500 panel for carbapenemase detection in carbapenem-resistant and carbapenem-susceptible Enterobacterales.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sensitivity and Specificity | 2020 |
Beta-lactams susceptibility testing of penicillin-resistant, ampicillin-susceptible Enterococcus faecalis isolates: a comparative assessment of Etest and disk diffusion methods against broth dilution.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Humans; Imipenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Sensitivity and Specificity | 2020 |
Simultaneous determination of meropenem and imipenem in rat plasma by LC-MS/MS and its application to a pharmacokinetic study.
Topics: Animals; Chromatography, Liquid; Imipenem; Linear Models; Male; Meropenem; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2021 |
Evaluation of the simplified carbapenem inactivation method as a phenotypic detection method for carbapenemase-producing Enterobacterales.
Topics: Anti-Bacterial Agents; Bacterial Load; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; False Positive Reactions; Imipenem; Meropenem; Sensitivity and Specificity | 2021 |
Multicenter evaluation of the RAPIDEC® CARBA NP test for rapid screening of carbapenemase-producing Enterobacteriaceae and Gram-negative nonfermenters from clinical specimens.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Colorimetry; Gram-Negative Bacterial Infections; Hospitals; Humans; Hydrolysis; Imipenem; Italy; Mass Screening; Predictive Value of Tests; Prospective Studies; Pseudomonas aeruginosa; Sensitivity and Specificity; Time Factors | 2017 |
A novel GoldNano Carb test for rapid phenotypic detection of carbapenemases, particularly OXA type, in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp.
Topics: Acinetobacter; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Colorimetry; Enterobacteriaceae; Enterobacteriaceae Infections; Gold; Humans; Imipenem; Metal Nanoparticles; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Pseudomonas aeruginosa; Sensitivity and Specificity | 2017 |
Is There a Carbapenem MIC Cutoff Value That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem Non-Susceptible Pseudomonas and Acinetobacter Isolates?
Topics: Academic Medical Centers; Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Centers for Disease Control and Prevention, U.S.; Drug Resistance, Microbial; Humans; Imipenem; Maryland; Meropenem; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections; ROC Curve; Sensitivity and Specificity; Thienamycins; United States | 2017 |
Detection of carbapenemase activity in Pseudomonas aeruginosa by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS).
Topics: Bacterial Proteins; beta-Lactamases; Cell Membrane; Cell Membrane Permeability; Colistin; Humans; Imipenem; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2018 |
Multiplex Immunochromatographic Detection of OXA-48, KPC, and NDM Carbapenemases: Impact of Inoculum, Antibiotics, and Agar.
Topics: Agar; Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Ertapenem; False Negative Reactions; Humans; Imipenem; Immunoassay; Meropenem; Sensitivity and Specificity; Time Factors | 2018 |
Direct detection of carbapenemase-associated proteins of Acinetobacter baumannii using nanodiamonds coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biomarkers; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Imipenem; Mass Spectrometry; Microbial Sensitivity Tests; Nanodiamonds; Polymerase Chain Reaction; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2018 |
Interpreting carbapenem susceptibility testing results for Pseudomonas aeruginosa.
Topics: beta-Lactam Resistance; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Reagent Strips; Sensitivity and Specificity | 2018 |
Establishment of a dual-wavelength spectrophotometric method for analysing and detecting carbapenemase-producing Enterobacteriaceae.
Topics: Absorption, Physicochemical; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Enterobacteriaceae Infections; Hydrolysis; Imipenem; Meropenem; ROC Curve; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Statistics, Nonparametric | 2018 |
Detection of carbapenemases, AmpC and ESBL genes in Acinetobacter isolates from ICUs by DNA microarray.
Topics: Acinetobacter; Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; DNA, Bacterial; Genes, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Molecular Typing; Oligonucleotide Array Sequence Analysis; Pakistan; Phenotype; Sensitivity and Specificity | 2018 |
An improved carbapenem inactivation method, CIMTrisII, for carbapenemase production by Gram-negative pathogens.
Topics: Acinetobacter; Anti-Bacterial Agents; Asia, Southeastern; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA, Bacterial; Enterobacteriaceae; Humans; Imipenem; Japan; Meropenem; Microbial Sensitivity Tests; Nepal; Pseudomonas; Sensitivity and Specificity; Sequence Analysis, DNA; Time Factors | 2019 |
Stability and degradation products of imipenem applying high-resolution mass spectrometry: An analytical study focused on solutions for infusion.
Topics: Chromatography, High Pressure Liquid; Drug Contamination; Drug Stability; Imipenem; Linear Models; Mass Spectrometry; Reproducibility of Results; Sensitivity and Specificity | 2019 |
Rapid detection of blaVIM-1-37 and blaKPC1/2-12 alleles from clinical samples by multiplex PCR-based assays.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Sensitivity and Specificity; Thienamycins | 2013 |
In vitro sensitivity of Acinetobacter baumannii and Pseudomonas aeruginosa to carbapenems among intensive care unit patients.
Topics: Acinetobacter baumannii; Bacterial Infections; Carbapenems; Doripenem; Electrophoresis, Gel, Pulsed-Field; Europe; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sensitivity and Specificity; Species Specificity; Thienamycins; United States; United States Food and Drug Administration | 2013 |
Nonvolatile salt-free stabilizer for the quantification of polar imipenem and cilastatin in human plasma using hydrophilic interaction chromatography/quadrupole mass spectrometry with contamination sensitive off-axis electrospray.
Topics: Acetonitriles; Chromatography, Liquid; Cilastatin; Humans; Hydrophobic and Hydrophilic Interactions; Imipenem; Linear Models; Methanol; Oseltamivir; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2013 |
Comparison of test methods for detecting metallo-β-lactamase-producing Gram-negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Sensitivity and Specificity | 2013 |
Functional Module Connectivity Map (FMCM): a framework for searching repurposed drug compounds for systems treatment of cancer and an application to colorectal adenocarcinoma.
Topics: Adenocarcinoma; Algorithms; Colorectal Neoplasms; Drug Repositioning; Epistasis, Genetic; Ethacrynic Acid; Gene Regulatory Networks; Ginkgolides; Humans; Imipenem; Indoles; Lactones; Microarray Analysis; Phenoxybenzamine; Sensitivity and Specificity; Thymine | 2014 |
Completely green synthesis of dextrose reduced silver nanoparticles, its antimicrobial and sensing properties.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Escherichia coli; Gelatin; Glucose; Green Chemistry Technology; Hydrogen Peroxide; Imipenem; Metal Nanoparticles; Microbial Sensitivity Tests; Microscopy, Electron; Oxidation-Reduction; Pseudomonas aeruginosa; Sensitivity and Specificity; Silver; Silver Nitrate; Solubility; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Surface Plasmon Resonance | 2014 |
Use of imipenem to detect KPC, NDM, OXA, IMP, and VIM carbapenemase activity from gram-negative rods in 75 minutes using liquid chromatography-tandem mass spectrometry.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Chromatography, Liquid; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Sensitivity and Specificity; Tandem Mass Spectrometry | 2014 |
Efficient Detection of Carbapenemase Activity in Enterobacteriaceae by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Less Than 30 Minutes.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Enterobacteriaceae; Humans; Hydrolysis; Imipenem; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2015 |
[Comparison of the modified Hodge test and the Carba NP test for detection of carbapenemases in Enterobacteriaceae isolates].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cilastatin; Enterobacteriaceae; Enzyme Assays; Humans; Imipenem; Microbial Sensitivity Tests; Phenotype; Sensitivity and Specificity | 2016 |
Evaluation of different pretreatment protocols to detect accurately clinical carbapenemase-producing Enterobacteriaceae by MALDI-TOF.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Clinical Laboratory Techniques; Enterobacter aerogenes; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Hydrolysis; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2016 |
Comparison of the Modified-Hodge test, Carba NP test, and carbapenem inactivation method as screening methods for carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Ertapenem; Imipenem; Meropenem; Microbial Sensitivity Tests; Sensitivity and Specificity; Thienamycins | 2016 |
Imipenem-avibactam: a novel combination for the rapid detection of carbapenemase activity in Enterobacteriaceae and Acinetobacter baumannii by matrix-assisted laser desorption ionization-time of flight mass spectrometry.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Enterobacteriaceae; Imipenem; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2017 |
Rapid direct detection of carbapenemase-producing Enterobacteriaceae in clinical urine samples by MALDI-TOF MS analysis.
Topics: Automation, Laboratory; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Enterobacteriaceae Infections; Flow Cytometry; Germany; Humans; Imipenem; Polymerase Chain Reaction; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors; Urine | 2017 |
Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftazidime; Chromatography, High Pressure Liquid; Drug Stability; Ertapenem; Humans; Imipenem; Meropenem; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Thienamycins | 2008 |
Evaluation of dipicolinic acid-based Mueller Hinton agar biplate for detection of IMP-1 and VIM-2 type metallo-beta-lactamase in imipenem non-susceptible gram negative bacilli.
Topics: Agar; Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactamases; Chelating Agents; Drug Resistance, Bacterial; Gram-Negative Bacteria; Imipenem; Picolinic Acids; Reagent Kits, Diagnostic; Sensitivity and Specificity | 2009 |
Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Disk Diffusion Antimicrobial Tests; Electrophoresis, Gel, Pulsed-Field; Hospitals, University; Humans; Imipenem; Phenotype; Polymerase Chain Reaction; Predictive Value of Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity | 2010 |
Can we use imipenem and meropenem Vitek 2 MICs for detection of suspected KPC and other-carbapenemase producers among species of Enterobacteriaceae?
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Enterobacteriaceae; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sensitivity and Specificity; Thienamycins | 2011 |
Imipenem disc for detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Sensitivity and Specificity | 2011 |
Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Doripenem; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Genotype; Hospitals, Urban; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phylogeny; Polymerase Chain Reaction; Sensitivity and Specificity; Thienamycins; United States | 2011 |
Comparison of culture media for detection of Acinetobacter baumannii in surveillance cultures of critically-ill patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anal Canal; Anti-Bacterial Agents; Bacteriological Techniques; Cohort Studies; Critical Illness; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Infection Control; Intensive Care Units; Sensitivity and Specificity; Sputum | 2011 |
Comparative evaluation of combined-disk tests using different boronic acid compounds for detection of klebsiella pneumoniae carbapenemase-producing enterobacteriaceae clinical isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Boronic Acids; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Phenotype; Sensitivity and Specificity; Thienamycins | 2011 |
Phenotypic detection of metallo-β-lactamase in imipenem-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; False Positive Reactions; Genotyping Techniques; Humans; Imipenem; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Sensitivity and Specificity | 2012 |
[Comparison of ertapenem-EMB Agar with traditional methods for screening carbapenem-resistant Klebsiella pneumoniae from rectal swabs].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Culture Media; Doripenem; Drug Resistance, Bacterial; Ertapenem; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Multiplex Polymerase Chain Reaction; Rectum; Sensitivity and Specificity; Thienamycins; Time Factors | 2012 |
Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Ceftazidime; Culture Media; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Reagent Strips; Sensitivity and Specificity | 2002 |
Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp.
Topics: Acinetobacter; beta-Lactamases; Drug Resistance; Edetic Acid; Humans; Imipenem; Pseudomonas; Reagent Kits, Diagnostic; Sensitivity and Specificity | 2002 |
Mutation prevention concentration of ceftriaxone, meropenem, imipenem, and ertapenem against three strains of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Drug Resistance, Microbial; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Microbial Sensitivity Tests; Mutation; Pharmacogenetics; Probability; Sensitivity and Specificity; Streptococcus pneumoniae; Thienamycins | 2003 |
Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-beta-lactamases in gram-negative bacilli.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Clavulanic Acid; Culture Media, Conditioned; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Sensitivity and Specificity | 2004 |
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cross Infection; Drug Interactions; Female; Humans; Imipenem; Male; Melitten; Methicillin Resistance; Microbial Sensitivity Tests; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus aureus | 2004 |
Metallo-beta-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Humans; Imipenem; Korea; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Population Surveillance; Pseudomonas; Sensitivity and Specificity | 2004 |
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Cefazolin; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Imipenem; Male; Mice; Mice, Inbred BALB C; Oligopeptides; Random Allocation; Sensitivity and Specificity; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 2005 |
Evaluation of Etest MBL for detection of blaIMP-1 and blaVIM-2 allele-positive clinical isolates of Pseudomonas spp. and Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Alleles; beta-Lactamases; beta-Lactams; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas putida; Sensitivity and Specificity | 2005 |
Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa.
Topics: Amikacin; Ceftazidime; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sensitivity and Specificity | 2005 |
Detection of Pseudomonas aeruginosa producing metallo-beta-lactamases in a large centralized laboratory.
Topics: Alberta; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Edetic Acid; Humans; Imipenem; Laboratories; Meropenem; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Pseudomonas aeruginosa; Regional Health Planning; Sensitivity and Specificity; Thienamycins | 2005 |
Sensitive EDTA-based microbiological assays for detection of metallo-{beta}-lactamases in nonfermentative gram-negative bacteria.
Topics: Bacteriological Techniques; beta-Lactamases; Edetic Acid; Escherichia coli; Evaluation Studies as Topic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Liquid chromatographic method for the simultaneous determination of imipenem and sulbactam in mouse plasma.
Topics: Animals; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Imipenem; Mice; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Sulbactam | 2006 |
Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clinical Protocols; Critical Care; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Incidence; Intensive Care Units; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Probability; Retrospective Studies; Sensitivity and Specificity; Tazobactam; Treatment Outcome | 2007 |
Simultaneous determination of cefepime, vancomycin and imipenem in human plasma of burn patients by high-performance liquid chromatography.
Topics: Adolescent; Anti-Bacterial Agents; Burns; Calibration; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Imipenem; Male; Middle Aged; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Vancomycin | 2007 |
Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; DNA, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Predictive Value of Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity; Spectrophotometry | 2008 |
Supplementation of growth media with Zn2+ facilitates detection of VIM-2-producing Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactamases; beta-Lactams; Culture Media; Edetic Acid; Greece; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity; Zinc | 2008 |
Determination of meropenem in plasma by high-performance liquid chromatography and a microbiological method.
Topics: Anti-Bacterial Agents; Calibration; Chromatography, High Pressure Liquid; Chromatography, Liquid; Evaluation Studies as Topic; Humans; Imipenem; Meropenem; Microbiological Techniques; Reference Standards; Sensitivity and Specificity; Thienamycins | 1995 |
Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
Topics: Aztreonam; Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Sensitivity and Specificity | 1995 |
In vitro activity of beta-lactamase inhibitors against clinical isolates of Acinetobacter species.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefotaxime; Ceftazidime; Ceftriaxone; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Sulbactam; Tazobactam | 1995 |
Discrepancies in susceptibility test results for imipenem employing different in vitro test methods and DIN 58,940 breakpoints.
Topics: Bacteriological Techniques; Colony Count, Microbial; Culture Media; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Reference Values; Sensitivity and Specificity | 1995 |
Comparison of sensititre broth microdilution and agar dilution susceptibility testing techniques for meropenem to determine accuracy, reproducibility, and predictive values.
Topics: Agar; Bacteria, Aerobic; Bacteria, Anaerobic; Culture Media; Drug Resistance, Microbial; Imipenem; Indicator Dilution Techniques; Meropenem; Microbial Sensitivity Tests; Predictive Value of Tests; Reproducibility of Results; Sensitivity and Specificity; Thienamycins | 1994 |
In vitro activity of biapenem against beta-lactamase producing Enterobacteriaceae.
Topics: beta-Lactamases; Cefotaxime; Enterobacteriaceae; Imipenem; Microbial Sensitivity Tests; Sensitivity and Specificity; Thienamycins | 1994 |
Determination of imipenem in plasma by high-performance liquid chromatography for pharmacokinetic studies in patients.
Topics: Chromatography, High Pressure Liquid; Drug Stability; Humans; Imipenem; Reproducibility of Results; Sensitivity and Specificity; Thienamycins; Ultrafiltration | 1997 |
Soluble penicillin-binding protein 2a: beta-lactam binding and inhibition by non-beta-lactams using a 96-well format.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Binding, Competitive; Biotechnology; Carbapenems; Carrier Proteins; Chemical Precipitation; Dimethyl Sulfoxide; Enzyme Inhibitors; Hexosyltransferases; Imidazoles; Imipenem; Kinetics; Methods; Micropore Filters; Muramoylpentapeptide Carboxypeptidase; Penicillin G; Penicillin-Binding Proteins; Peptidyl Transferases; Recombinant Proteins; Sensitivity and Specificity; Solubility; Triazines; Tritium | 1998 |
Endotoxin release due to ciprofloxacin measured by three different methods.
Topics: Anti-Infective Agents; Bacterial Toxins; Ceftazidime; Cephalosporins; Ciprofloxacin; Endotoxins; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Humans; Imipenem; Limulus Test; Lipopolysaccharides; Monocytes; Sensitivity and Specificity; Thienamycins; Tumor Necrosis Factor-alpha | 1999 |
Use of surrogate antimicrobial agents to predict susceptibility to ertapenem.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Oxacillin; Penicillins; Sensitivity and Specificity; Thienamycins | 2002 |
False resistance to imipenem with a microdilution susceptibility testing system.
Topics: Cystic Fibrosis; Drug Resistance, Microbial; Escherichia coli; False Positive Reactions; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quality Control; Sensitivity and Specificity | 1991 |